P

Inventor

HANSEN JOSHUA

US47 patents
⚠️ This page may combine multiple inventors who share the name “HANSEN JOSHUA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CELGENE CORP

30 patents
US9499514B2Nov 22, 2016

Antiproliferative compounds and methods of use thereof

CELGENE CORP28 citations93
US10357489B2Jul 23, 2019

Antiproliferative compounds and methods of use thereof

CELGENE CORP20 citations92
US11149007B2Oct 19, 2021

Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith

CELGENE CORP14 citations84
US11325889B2May 10, 2022

Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith

CELGENE CORP11 citations83
US10227325B2Mar 12, 2019

Antiproliferative compounds, and their pharmaceutical compositions and uses

CELGENE CORP6 citations83
US9938254B2Apr 10, 2018

Antiproliferative compounds, and their pharmaceutical compositions and uses

CELGENE CORP5 citations83
US11185543B2Nov 30, 2021

Antiproliferative compounds and methods of use thereof

CELGENE CORP5 citations82
US9968596B2May 15, 2018

Antiproliferative compounds and methods of use thereof

CELGENE CORP8 citations82
US9808451B2Nov 7, 2017

Antiproliferative compounds and methods of use thereof

CELGENE CORP12 citations82
US11634407B2Apr 25, 2023

Cereblon binding compounds, compositions thereof, and methods of treatment therewith

CELGENE CORP5 citations73
US11241423B2Feb 8, 2022

Antiproliferative compounds and methods of use thereof

CELGENE CORP2 citations72
US10969381B2Apr 6, 2021

Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile

CELGENE CORP1 citations72
US10618883B2Apr 14, 2020

Antiproliferative compounds, and their pharmaceutical compositions and uses

CELGENE CORP1 citations72
US11873283B2Jan 16, 2024

Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith

CELGENE CORP2 citations71
US11739075B2Aug 29, 2023

Cereblon binding compounds, compositions thereof, and methods of treatment therewith

CELGENE CORP3 citations71
US11726080B2Aug 15, 2023

Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-l-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile

CELGENE CORP1 citations71
US11560371B2Jan 24, 2023

Cereblon binding compounds, compositions thereof, and methods of treatment therewith

CELGENE CORP3 citations71
US11365184B2Jun 21, 2022

Antiproliferative compounds, and their pharmaceutical compositions and uses

CELGENE CORP0 citations62
US12510533B2Dec 30, 2025

Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile

CELGENE CORP0 citations61
US12404241B2Sep 2, 2025

Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith

CELGENE CORP0 citations61
US12227490B2Feb 18, 2025

Cereblon binding compounds, compositions thereof, and methods of treatment therewith

CELGENE CORP0 citations61
US12103920B2Oct 1, 2024

Cereblon binding compounds, compositions thereof, and methods of treatment therewith

CELGENE CORP0 citations61
US11945804B2Apr 2, 2024

Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith

CELGENE CORP0 citations61
US11358952B2Jun 14, 2022

Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith

CELGENE CORP1 citations60
US12577223B2Mar 17, 2026

Processes for preparing 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

CELGENE CORP0 citations59
US12029738B2Jul 9, 2024

Antiproliferative compounds and methods of use thereof

CELGENE CORP0 citations59
US11312699B2Apr 26, 2022

Processes for preparing 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

CELGENE CORP0 citations59
US12486281B2Dec 2, 2025

Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith

CELGENE CORP0 citations56
US11306101B2Apr 19, 2022

Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith

CELGENE CORP0 citations56
US10675281B2Jun 9, 2020

Antiproliferative compounds and methods of use thereof

CELGENE CORP0 citations51

SIGNAL PHARM LLC

10 patents

ATLASSIAN PTY LTD

3 patents

HANSEN JOSHUA

2 patents

BRINTON BRETT

1 patent

BRISTOL MYERS SQUIBB CO

1 patent